Treg activation defect in type 1 diabetes: correction with TNFR2 agonism
Nature.com Baseline characteristics of the subjects used in this study are presented in Supplementary Table 1. Blood was processed within 2 h of phlebotomy. HbA1c measurements were performed by the clinical laboratories at the Massachusetts General Hospital. |
from phlebotomy - Google News http://bit.ly/1OeXj4n
No comments:
Post a Comment